Allogeneic Stem Cell Transplantation for Patients With Multiple Myeloma

NCT02447055 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Conditions

Multiple Myeloma
Myeloma-Multiple

Interventions

BIOLOGICAL: Tocilizumab
DRUG: Melphalan
DRUG: Fludarabine
DRUG: Cyclophosphamide
DRUG: Tacrolimus
DRUG: Mycophenolate mofetil
DRUG: Filgrastim

Sponsor

Washington University School of Medicine